Eli Lilly said it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more ...

Eli Lilly is cutting what self-paying patients shell out for its blockbuster obesity drug Zepbound when they buy single-dose ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

The decision is the latest in a series of moves to make its GLP-1 blockbuster more widely available and affordable.

Online telehealth company Hims and Hers Health HIMS.N is launching its weight-loss membership and treatment plans in the UK ...

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic shift. Zealthy is one of the fastest-growing telehealth weight-loss platforms in the ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

As people’s bodies change because of GLP-1s, so does their spending across industries including fashion, restaurants, gyms ...

Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or ...

Bristol Myers Squibb said it will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer’s disease, after the company found “irregularities due to ...

One state, North Dakota, has taken a different approach to GLP-1 coverage after legislation that would have required the ...